• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-020
Device Problems Migration or Expulsion of Device (1395); Human-Device Interface Problem (2949)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 09/15/2021
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported on (b)(6) 2021, a 20mm amplatzer septal occluder was selected for implant.After positioning, the doctor performed the "wiggle" test and waited 5 minutes.The doctor performed another "wiggle" test and pulled the sheath down a little so the cable could move loosely and during that time a transesophageal echocardiogram (tee) was performed and a small cranial/posterior shunt was noted.The doctor wanted to implant a 22mm but didn't.After the tee another "wiggle" test was performed and the occluder fit well.Soon after the occluder embolized and was positioned in front of the aortic valve.The occulder did not block or damage any valves and blood was still able to flow through.A 12f sheath and cardio forceps were used to guide the occluder over the aorta and into the grown.It was then retrieved via a 20f sheath.The mitral, aortic valve, septum and pericardium were checked on tee and nothing was noted.The angio of the vessels were also normal.No device was implanted.The patient received a ct scan and is being monitored.On (b)(6), the patient was operated on during the night due to 2 small lesions possible due to the guidewire causing the bleed into the abdomen.The patient is doing well due to the circumstances.
 
Manufacturer Narrative
An event of residual shunt and device embolism was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
MDR Report Key12511816
MDR Text Key272668916
Report Number2135147-2021-00375
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010175
UDI-Public00811806010175
Combination Product (y/n)N
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model Number9-ASD-020
Device Catalogue Number9-ASD-020
Device Lot Number6910041
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-